Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the Company’s website, www.viadermalicensing.com.
The letter contains updates on future sales, Dr. Otiko’s recent trip to India as well as several other key developments. Some of the other items in the letter include:
Registration of Vitastem with the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria’s equivalent to the FDA is in the final stages and expected to be completed very soon. At that time, Vage Nigeria Ltd. will pay a 50% deposit to ViaDerma in the amount of $125,000 for its initial order worth $250,000.
Discussions with a South American distributor are ongoing and expected to result in a purchase of 200,000 units of Vitastem per month.
The Company is realizing significant month to month increases in Vitastem sales on Amazon.
Registering of Vitastem for medical insurance coverage is underway and expected to have final approval for insurance payments and reimbursements for January 2019.
Additionally, the Company is announcing they are close to finalizing a sales agreement for 10,000 units per month of Vitastem with a distributor in Vietnam.
Also, ViaDerma is in early stage discussions to have their product, Viastem sold in Direct Response ads on TV, and distributed through a network of 600 Skilled Nursing Facilities in California and 5000 hospitals in the east coast.
ViaDerma President, Dr. Christopher Otiko said, “As I pointed out in my recent letter to shareholders, we are very excited about our future and our current trajectory. In spite of some minor delays, we remain optimistic this will be a very strong year for ViaDerma.”
ViaDerma, Inc. (OTC:VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, please visit: www.viadermalicensing.com
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310-374-6111
Just speak for yourself. The odds are pretty slim that there will be news of any significance based on management's recent past. It has now been 6 months since the last fluffy "Shareholders update".
This last mini rally is all based on someone said that they talked to IR and they're really excited about them closing a deal in mid November. Now that's some really sound investment advice.
I would suggest to anyone holding the bag, to take advantage of the current liquidity to dump the trash.
"The Company distributes MagneGas2® through Independent Distributors in the U.S and through its wholly owned distributors, ESSI, Green Arc Supply, Paris Oxygen, Latex Welding Supplies, United Welding Specialties, Trico Welding Supply and Complete Welding of San Diego. ESSI has 4 locations in Florida, Green Arc and Paris Oxygen have 4 locations in Texas, Green Arc and Latex have two locations in Louisiana, Trico has two locations in northern California, and Complete Welding has one location in southern California."
magnegas.com/
What businesses MNGA will buy next to help improve their bottom line.
I have "News" for you... Your $$$ will "Soon" be gone!
Don't buy this stock until the news is actually released.
The Brewer Group, Greentree Financial...
TBG Headquarters:
7951 S.W. 6th Street
Suite 216
Plantation, FL 33324
?P: 1.866.955.6267
F: 1.866.955.6267
E: info@thebrewergroup.com
________________________________
Greentree Financial
Florida Office
R. Chris Cottone
Greentree Financial Group, Inc.
7951 SW 6th Street, Suite 216 Plantation, FL 33324
North Carolina Office
Michael J. Bongiovanni, MBA
Greentree Financial Group, Inc.
19720 Jetton Road, 3rd Floor Penthouse Cornelius, NC 28031
(704) 892-8733 Office (704) 892-6487 Fax mikebongiovanni@gtfinancial.com
Accountant: L&L CPAS PA 19720 Jetton Road, 3rd Floor Cornelius, NC 28031 Phone: (704) 897-8336 Fax: (704) 919-5089 Email: tluo@llcpas.net
Unfortunately, I think you are correct. My tipping point to sell came when I did some serious DD a few months ago and discovered that the Brewer Group, the accountant and Greentree financial(debt holder) all receive convertible shares last year and they all work out of same building complex in Plantation FL. This sure appears to be fishy and not in the best interest of the shareholders.
What are we waiting for now? Oh, that's right, someone called the Doc and they were moved by the doc's enthusiasm for a deal to close "Soon" or in mid November and they post their findings on this board. Meanwhile, it appears that the management choose to go into a "Blackout Period" to avoid making additional false statements and to just go with word of mouth to keep shareholders informed.
Talk about an agenda! Sure, let me throw a few thousand bucks at that solid info.
We should also point out that we are now at that time of year when Otiko likes to trade 100's of millions of shares at the Brewer Group for media services and more shares toward "Consultation Fees".
VDRM is just going to fade away.
Salesman he is not and not much of a CEO either. I believe the problems here are much deeper than what is laying on the surface.
As for the Vitastem, I'm a believer. I have used the product many times. I have a bottle of it right here on the table next to my chair. I work with metal and also occasionally on cars where I occasionally pick up a metal sliver and they seem to fester up. I use Vitastem on it and rest assured that it will heal rapidly and it always does.
The way I see the future for VDRM, it is unlikely they will land a paid on deal. The sales of Vitastem last quarter was pathetic compared to what we were lead to believe. If he does come though with the a deal, any deal the stock price will go up, but not like it has in the past. Way too many shares out there now and too many convertible shares to pay for services. On top of all that, the herd moved on. They're still watching like I am, but the trust has been lost. Too many "soon" in the narrative for my investing objective.
One must ask themselves, if the a deal isn't consummated soon, will there ever going to be one. The Doc has been a great promoter to get the company started, but he has absolutely no follow through.
If he pulls this deal off successfully I'll get back in, but I'm not going to trust the doc with my money anymore while waiting for "Soon" to materialize.
Yes
Today's Webcast at 5PM est. https://services.choruscall.com/links/nlst181108.html
Just stating the facts and I don't really care if you like me or not. I watch this stock each day and I don't believe there're are many that know this company like I do to prove me wrong. I would like nothing more than to see this take off, but we both know that it is unlikely. If the Doc can actually close a deal, I'll get back in and it doesn't matter at what price, I trade momentum.
Don't count on a big deal soon. I would like nothing more than to see you guys make a lot of money on this stock, however I don't think the doc can close any deal at this point. Why has he not at the least hired a sales force he promoted. Where is the 3800 store pharmacy distribution deal that he promoted. When will the Elixr products production start. I'm sorry but I have lost all faith in the CEO Otiko weeks ago and he has done nothing to convince me that he is turning this ship around. I do wish things were different but the reality has proven this product and this management team (or lack of one) has failed us.
VDRM management MIA
Every time the PPS drops below $.29 big volume buy grabs them ASAP. MNGA is going higher over the next few weeks.
$MNGA has gas!
MNGA appears to be holding up pretty good, it maybe a green day after all.
As we all know a RS usually results in a decline in PPS, but that isn't always the outcome. The net effect of a RS is zero, it's the fear of a PPS decrease that people act on. I personally am confident in the management ability to move the company forward successfully toward profitability. The product(s) to replace acetylene gas is a game changer. Market penetration will happen quickly with a gas that burns cleaner and 10x hotter than acetylene. This will benefits the consumers by reducing the amount of gas volume needed to meet their production needs.
I'm maintaining a "Buy" on MNGA.
The Board of Directors believes that the reverse stock split will provide a number of benefits to MagneGas and its existing stockholders, which may lead to an increase in investor interest, including:
1. Reduced Short-Term Risk of Illiquidity. The Board of Directors understands that a higher stock price may increase investor confidence by reducing the short-term risk of illiquidity and lack of marketability of the common stock that may result from the delisting of the common stock from Nasdaq.
2. Decreasing Transaction Costs. Investors may also be dissuaded from purchasing stocks below certain prices because the brokerage commissions, as a percentage of the total transaction value, tend to be higher for such low-priced stocks.
3. Stock Price Requirements. The Board of Directors understands that some brokerage houses and institutional investors may have internal policies and practices that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending low-priced stocks to their customers or by restricting or limiting the ability to purchase such stocks on margin. In addition, analysts at brokerage firms may not monitor the trading activity or otherwise provide coverage of lower priced stocks.
Other Potential Benefits
The Board of Directors believes that a higher stock price would help MagneGas attract and retain employees and other service providers. It is the view of the Board of Directors that some potential employees and service providers are less likely to work for a company with a low stock price, regardless of the size of the company’s market capitalization. Accordingly, if the reverse stock split successfully increases the per share price of the common stock, the Board of Directors believes this increase will enhance MagneGas’s ability to attract and retain employees and service providers.
Big buyers waiting in the weeds.
I don’t know if they are ready to manufacture the product at this time, however the manufacturing facility will need to pass an FDA inspection in the 3rd phase of the approval process.
Thanks for your reply. Here is the outline of what "Break Though Designation" employs. From a quick glance, the BTD looks to speed the process up to bring the products to market. https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM581664.pdf
The Brewer Group is a joke. This is the second marketing contract. All we get is FaceBook ads and they get millions of VDRM shares.
I have post in the past about Brewer Group. The Brewer group just so happen to share the same office building as the account hired by Viaderma and also the same office as the Greentree Financial, a VDRM convertible debt holder. Think about that set-up, very shady.
I don't know how much DD you did on the company and product, but they have tried and failed to with this business model back in 2014. Dr. Otiko convinced Phillips to try it again and is just won't sell. I think the product does wonders to heal wounds, but it just can't get traction.
I have seen companies behaving like this suddenly get "Locked" by the SEC and all you get after that is stuck with shares you can't sell. I beginning to think a "Lock" will come sooner then a penned deal.
I think 90+ days is beyond the scope of "Soon".
This stock is pathetic. With this kind of FDA designation the PPS should be skyrocketing. Either the company or a debt holder pulled this stock down. Has all the signs of a true P&D.
VDRM is just sad.
Suddenly a premarket interest in MNGA. Looking for a "Green Day"!
{{{ALL ABOARD!!!}}} Next stop $.80TH and Greenland.
With only 38 million outstanding shares and huge volume equals "Locked-up" float and higher PPS.
Buy and Hold and $$$ will come.
{{{{{Shake that Tree!}}}}} Nothing quite like a dip to trigger the "Stop-loss" condition.
MagneGas2® will replace acetylene because of the higher temperatures it produces.
MagneGas2 compared to acetylene... The tests were highly favorable and support the Company’s claims that MagneGas2® is an extremely stable, safer alternative to acetylene, the most widely-used metal cutting fuel used globally today.
This is HUGE volume, buy now it's still cheap!
MNGA is trading like there's a buyout in the works. Who knows, with the "New Branding" and all.
JMHO
I am not uncertain that MNGA is going to be a huge winner over the next few years. When the big metal works industries begin to buy this new gas in bulk, PPS will be over $5.00 and I don't think we'll have to wait very long.
Zzzzzzzzzzzzzz...
Buyers dried up moving to OTC, where as the Nasdaq provided liquidity. I believe the PPS will evaporate between now and a settlement disclosure. With that said; as the PPS drops, watch for large lots sneaking through under the radar as the institutional buyers quietly accumulate shares.
Buy wisely.
Although today's news appears to be negative, it draws a lot of attention to the stock. Once they read the background of this company, they buy in and hold.
More eyeballs the better.
Round Two! Hoard on the dips.